Jennison Associates LLC Praxis Precision Medicines, Inc. Transaction History

Jennison Associates LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$10.21 - $20.29 $1.98 Million - $3.93 Million	-193,834 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$16.76 - $22.99 $26,614 - $36,508	-1,588 Reduced 0.81%	193,834 $3.82 Million
Q3 2021 Nov 09, 2021	SELL	$13.15 - $22.56 $27,457 - $47,105	-2,088 Reduced 1.06%	195,422 $3.61 Million
Q1 2021 May 11, 2021	SELL	$29.34 - $60.2 $48,851 - $100,233	-1,665 Reduced 0.84%	197,510 $6.47 Million
Q4 2020 Feb 05, 2021	BUY	$27.25 - $55.82 $5.43 Million - $11.1 Million	199,175 New	199,175 $11 Million

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.